Ingenox Therapeutics Limited
- Company number
- 14127227
- Status
- Active
- Type
- Private Limited Company
- Incorporated
- 24 May 2022
- Nature of business
- Activities of other holding companies n.e.c.
Research and experimental development on biotechnology
Registered office
Previous names
- Celleron Therapeutics Holdings Limited (until 26 Jan 2023)
Control
| Name | Nature of control | Notified | Ceased |
|---|---|---|---|
| Prof Nicholas Barrie La Thangue | Ownership Of Shares 75 To 100 Percent Voting Rights 75 To 100 Percent Right To Appoint And Remove Directors |
24 May 2022 | 22 Dec 2022 |
| Patrick Soon-Shiong | Voting Rights 50 To 75 Percent Right To Appoint And Remove Directors |
19 Apr 2024 |
Accounts
| Year ended | Net assets | Cash | Employees |
|---|---|---|---|
| 31 Dec 2025 | -£9,665,953 | £356,895 | 0 |
| 31 Dec 2024 | -£5,206,795 | £1,040,043 | 0 |
| 30 Jun 2023 | - | - | - |
Connections
Controls
- Argonaut Therapeutics Limited (09993166)
- Celleron Therapeutics Limited (05162047)
Companies at the same address
- Argonaut Therapeutics Limited (09993166)
- Celleron Therapeutics Limited (05162047)
- Prophase Development Limited (05167257)